These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 9313951)

  • 81. Synthesis and theoretical studies on energetics of novel N- and O- perfluoroalkyl triazole tagged thienopyrimidines--their potential as adenosine receptor ligands.
    Sirisha B; Narsaiah B; Yakaiah T; Gayatri G; Sastry GN; Prasad MR; Rao AR
    Eur J Med Chem; 2010 May; 45(5):1739-45. PubMed ID: 20116907
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Further characterization of a CNS adenosine A2a receptor ligand [11C]KF18446 with in vitro autoradiography and in vivo tissue uptake.
    Ishiwata K; Ogi N; Shimada J; Nonaka H; Tanaka A; Suzuki F; Senda M
    Ann Nucl Med; 2000 Apr; 14(2):81-9. PubMed ID: 10830524
    [TBL] [Abstract][Full Text] [Related]  

  • 83. A(2A) adenosine receptors and Parkinson's disease severity.
    Casetta I; Vincenzi F; Bencivelli D; Corciulo C; Gentile M; Granieri E; Borea PA; Varani K
    Acta Neurol Scand; 2014 Apr; 129(4):276-81. PubMed ID: 24032478
    [TBL] [Abstract][Full Text] [Related]  

  • 84. [Protective effect of new adenosine analog B2 against serum deprivation-induced PC12 cell injury].
    Sun J; Li M; Kang RX; Shi JG; Zhang JJ
    Yao Xue Xue Bao; 2011 Oct; 46(10):1199-203. PubMed ID: 22242450
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Expeditious synthesis and biological evaluation of new C-6 1,2,3-triazole adenosine derivatives A1 receptor antagonists or agonists.
    Mathew SC; By Y; Berthault A; Virolleaud MA; Carrega L; Chouraqui G; Commeiras L; Condo J; Attolini M; Gaudel-Siri A; Ruf J; Rodriguez J; Parrain JL; Guieu R
    Org Biomol Chem; 2010 Sep; 8(17):3874-81. PubMed ID: 20617271
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Allosteric modulation of A(2A) adenosine receptors by amiloride analogues and sodium ions.
    Gao ZG; Ijzerman AP
    Biochem Pharmacol; 2000 Sep; 60(5):669-76. PubMed ID: 10927025
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Striatal A2A adenosine receptor antagonism differentially modifies striatal glutamate outflow in vivo in young and aged rats.
    Corsi C; Melani A; Bianchi L; Pedata F
    Neuroreport; 2000 Aug; 11(11):2591-5. PubMed ID: 10943728
    [TBL] [Abstract][Full Text] [Related]  

  • 88. SCH 58261 (an adenosine A(2A) receptor antagonist) reduces, only at low doses, K(+)-evoked glutamate release in the striatum.
    Pintor A; Quarta D; Pèzzola A; Reggio R; Popoli P
    Eur J Pharmacol; 2001 Jun; 421(3):177-80. PubMed ID: 11516434
    [TBL] [Abstract][Full Text] [Related]  

  • 89. [(3)H]ZM241385--an antagonist radioligand for adenosine A(2A) receptors in rat brain.
    Alexander SP; Millns PJ
    Eur J Pharmacol; 2001 Jan; 411(3):205-10. PubMed ID: 11164377
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Adenosine A1 and A2A receptor antagonists stimulate motor activity: evidence for an increased effectiveness in aged rats.
    Popoli P; Reggio R; Pèzzola A; Fuxe K; Ferré S
    Neurosci Lett; 1998 Jul; 251(3):201-4. PubMed ID: 9726378
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Subtype-Selective Fluorescent Ligands as Pharmacological Research Tools for the Human Adenosine A
    Comeo E; Kindon ND; Soave M; Stoddart LA; Kilpatrick LE; Scammells PJ; Hill SJ; Kellam B
    J Med Chem; 2020 Mar; 63(5):2656-2672. PubMed ID: 31887252
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Pyrazolo-triazolo-pyrimidine derivatives as adenosine receptor antagonists: a possible template for adenosine receptor subtypes?
    Baraldi PG; Cacciari B; Borean PA; Varanin K; Pastorin G; Da Ros T; Tabrizi MA; Fruttarolo F; Spalluto G
    Curr Pharm Des; 2002; 8(26):2299-332. PubMed ID: 12369947
    [TBL] [Abstract][Full Text] [Related]  

  • 93. 1,2,3-Triazolo[5,4-e]1,2,4-triazolo[1,5-c]pyrimidine derivatives: a new class of A2A adenosine receptor antagonists.
    Baraldi PG; Cacciari B; Spalluto G; Pineda de las Infants MJ; Zocchi C; Ferrara S; Dionisotti S; FerraDDionisotti S
    Farmaco; 1996 Apr; 51(4):297-300. PubMed ID: 8645419
    [No Abstract]   [Full Text] [Related]  

  • 94. Binding kinetics of ZM241385 derivatives at the human adenosine A2A receptor.
    Guo D; Xia L; van Veldhoven JP; Hazeu M; Mocking T; Brussee J; Ijzerman AP; Heitman LH
    ChemMedChem; 2014 Apr; 9(4):752-61. PubMed ID: 24591302
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Synthesis and preliminary biological evaluation of [3H]-MRE 3008-F20: the first high affinity radioligand antagonist for the human A3 adenosine receptors.
    Baraldi PG; Cacciari B; Romagnoli R; Varani K; Merighi S; Gessi S; Borea PA; Leung E; Hickey SL; Spalluto G
    Bioorg Med Chem Lett; 2000 Feb; 10(3):209-11. PubMed ID: 10698437
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Site-directed mutagenesis studies of human A(2A) adenosine receptors: involvement of glu(13) and his(278) in ligand binding and sodium modulation.
    Gao ZG; Jiang Q; Jacobson KA; Ijzerman AP
    Biochem Pharmacol; 2000 Sep; 60(5):661-8. PubMed ID: 10927024
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Characterization and preliminary use of 1-, 2- and 3-methyl-5-phenyl-7-chloro-1,2,3-triazolo[4,5-d]pyrimidine as reaction intermediates.
    Biagi G; Giorgi I; Livi O; Scartoni V; Barili PL
    Farmaco; 2003 Aug; 58(8):551-6. PubMed ID: 12875884
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Adenosine A2A receptor agonists: CoMFA-based selection of the most predictive conformation.
    Doytchinova I; Valkova I; Natcheva R
    SAR QSAR Environ Res; 2002 Mar; 13(2):227-35. PubMed ID: 12071651
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Alteration of A(3) adenosine receptors in human neutrophils and low frequency electromagnetic fields.
    Varani K; Gessi S; Merighi S; Iannotta V; Cattabriga E; Pancaldi C; Cadossi R; Borea PA
    Biochem Pharmacol; 2003 Nov; 66(10):1897-906. PubMed ID: 14599547
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Effects of A(1) and A(2A) adenosine receptor ligands in mouse acute models of pain.
    Bastia E; Varani K; Monopoli A; Bertorelli R
    Neurosci Lett; 2002 Aug; 328(3):241-4. PubMed ID: 12147316
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.